0
Letters |

CYP2C19 Genotype and Cardiovascular Events—Reply

Steven E. Nissen, MD
JAMA. 2012;307(14):1482-1485. doi:10.1001/jama.2012.447.
Text Size: A A A
Published online

Extract

In Reply: Dr Shuldiner and colleagues criticize my assertion that physicians should require a prospective randomized trial before using CYP2C19 pharmacogenomics in clinical practice. Specifically, they state that such a conservative approach “may be denying patients access to potentially life-saving individualized alternative therapies.”

I could not more strongly disagree. For decades, women were treated with hormone therapy to prevent heart disease based on observational studies, only to find out that such treatments increase, rather than decrease, morbidity and mortality.1,2 Similarly, inappropriate use of surrogate end points has repeatedly promoted adoption of therapies that later proved ineffective or harmful. Examples include drugs to increase high-density lipoprotein cholesterol or reduce blood glucose such as rosiglitazone.3,4 Platelet reactivity testing represents another unvalidated surrogate end point and cannot be a substitute for studies that measure morbidity and mortality, which are the outcomes of importance to patients and physicians.

Topics

Sign In to Access Full Content

Don't have Access?

Register and get free email Table of Contents alerts, saved searches, PowerPoint downloads, CME quizzes, and more

Subscribe for full-text access to content from 1998 forward and a host of useful features

Activate your current subscription (AMA members and current subscribers)

Purchase Online Access to this article for 24 hours

First Page Preview

View Large
/>
First page PDF preview

Figures

Tables

References

April 11, 2012
Alan R. Shuldiner, MD; Mark R. Vesely, MD; Adam Fisch, BS
JAMA. 2012;307(14):1482-1485. doi:10.1001/jama.2012.443.
April 11, 2012
Jessica L. Mega, MD, MPH; Eric J. Topol, MD; Marc S. Sabatine, MD, MPH
JAMA. 2012;307(14):1482-1485. doi:10.1001/jama.2012.444.
April 11, 2012
Gerasimos Siasos, MD, MSc, PhD; Dimitris Tousoulis, MD, PhD; Christodoulos Stefanadis, MD, PhD
JAMA. 2012;307(14):1482-1485. doi:10.1001/jama.2012.445.
April 11, 2012
Michael V. Holmes, MBBS, MSc; Aroon D. Hingorani, FRCP, PhD; Juan P. Casas, MD, PhD
JAMA. 2012;307(14):1482-1485. doi:10.1001/jama.2012.446.
CME
Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.
NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).

Multimedia

Some tools below are only available to our subscribers or users with an online account.

Sign In to Access Full Content

Related Content

Customize your page view by dragging & repositioning the boxes below.

See Also...
Jobs
brightcove.createExperiences();